Stocks · Health care · Pharmaceutical Preparations

Olema Pharmaceuticals, Inc.

OLMA Clue Score20
United States Fiscal year ends December CIK 0001750284 Results filed 10 Aug 2026

What the insiders did Net buying

Insider
Date
Role
Action
Shares
Price
Amount
Bain Capital Life Sciences Investors, LLC
8 Jan 2025
10% owner
Buy indirect
300,000
$5.76
$1.73M
G. Walmsley Graham
17 Dec 2024
Director
Buy indirect
700,761
$6.75
$4.73M
Paradigm Biocapital Advisors LP
6 Dec 2023
10% owner
Buy indirect
100,000
$11.60
$1.16M
G. Walmsley Graham
5 Dec 2023
Director
Buy indirect
50,000
$13.09
$654.25K
G. Walmsley Graham
5 Dec 2023
Director
Buy indirect
50,000
$14.95
$747.48K
G. Walmsley Graham
5 Dec 2023
Director
Buy indirect
31,870
$14.73
$469.55K
Bvf Partners L P/Il
12 Sep 2023
Director
Buy
52,801
$9.84
$519.56K
Bvf Partners L P/Il
12 Sep 2023
Director
Buy
677,853
$9.84
$6.67M
Bvf Partners L P/Il
12 Sep 2023
Director
Buy
775,278
$9.84
$7.63M
G. Walmsley Graham
12 Sep 2023
Director
Buy indirect
508,130
$9.84
$5.00M
Shane William Charles Kovacs
6 Apr 2023
Ch. Operating & Financial Off.
Buy
10,000
—
no price
Shane William Charles Kovacs
2 Sep 2022
Ch. Operating & Financial Off.
Buy
20,000
—
no price
Bvf Partners L P/Il
10 Jun 2022
Director
Buy
41,417
$4.03
$167.10K
Bvf Partners L P/Il
10 Jun 2022
Director
Buy
158,583
$4.03
$639.80K
Bvf Partners L P/Il
30 Nov 2021
Director
Buy
35,268
$9.39
$331.18K
Bvf Partners L P/Il
30 Nov 2021
Director
Buy
341,977
$9.39
$3.21M
Bvf Partners L P/Il
30 Nov 2021
Director
Buy
362,430
$9.39
$3.40M
G. Walmsley Graham
23 Nov 2020
Director
Buy indirect
1,160,000
$19.00
$22.04M
Cormorant Asset Management, LP
23 Nov 2020
Former 10% Owner
Buy indirect
425,000
$19.00
$8.08M
Bvf Partners L P/Il
19 Nov 2020
Director
Buy
74,991
$19.00
$1.42M
Bvf Partners L P/Il
19 Nov 2020
Director
Buy
446,425
$19.00
$8.48M
Bvf Partners L P/Il
19 Nov 2020
Director
Buy
613,918
$19.00
$11.66M

What was left out

Form 4 filings counted 203
Amendments (4/A) skipped 14
Filings about a different issuer 0
Unreadable filings 0
Joint filings 15
Sales on a Rule 10b5-1 plan 26
Sales straight out of an exercise 36
Sales at will 65
Transactions with no price 2
Shares from compensation/vesting 24,931,528
Sales filed before the plan box existed 11
History held since 19 Nov 2020